Tutorials › VEE Accounting and Finance › Estimating Comparable Betas With Regression Diagnostics

VEE Accounting and Finance · Project and Divisional Discount Rates · Tutorial 680 of 996

Estimating Comparable Betas With Regression Diagnostics

Use regression diagnostics to judge whether an estimated beta is a useful measure of project risk and understand how estimation choices affect a project discount rate.

Advanced 10 min read

What You'll Learn

  • Define regression beta and explain the assumptions behind its ordinary least squares estimate.
  • Assess how return frequency and estimation period affect beta reliability and interpretation.
  • Explain why a market-index choice can change estimated beta and a CAPM-based discount rate.
  • Diagnose the potential bias from thin trading and nonsynchronous price observations.
  • Evaluate how outliers and influential observations can shift an estimated beta.
  • Translate beta uncertainty into a project discount-rate implication without treating diagnostics as automatic adjustments.

Why Beta Estimation Requires Diagnostics

A regression beta is an estimate, not a permanent characteristic known with certainty. It depends on which asset returns are observed, how often they are measured, which market index is used, and which dates are included. Those choices matter when a beta is used to assess a project’s systematic risk and, through the CAPM, its cost of equity.

For project discounting, a beta estimate should be economically relevant as well as computationally correct. A regression can produce a precise-looking slope even when its return frequency is poorly matched, the security trades infrequently, or a small number of observations dominate the result. Diagnostics help identify those weaknesses; they do not justify changing a beta mechanically.

Definition: In a market-model regression, the asset’s return \(R_{i,t}\) in period \(t\) is related to the market index return \(R_{m,t}\) by \(R_{i,t}=\alpha+\beta R_{m,t}+\varepsilon_t\). The regression beta \(\beta\) measures the asset’s estimated sensitivity to the chosen index: it is the expected change in the asset return associated with a one-unit change in the index return, under the fitted linear model. The intercept is \(\alpha\), and \(\varepsilon_t\) is the residual.

The Regression Estimate and Its Meaning

With \(n\) paired observations at the same frequency, ordinary least squares (OLS) chooses an intercept and slope to minimize the sum of squared residuals. The estimated slope is

$$ \hat{\beta}= \frac{\sum_{t=1}^{n}(R_{m,t}-\bar R_m)(R_{i,t}-\bar R_i)} {\sum_{t=1}^{n}(R_{m,t}-\bar R_m)^2} = \frac{\widehat{\operatorname{Cov}}(R_m,R_i)} {\widehat{\operatorname{Var}}(R_m)}. $$

Here \(\bar R_m\) and \(\bar R_i\) are the sample means. Using sample covariance and sample variance with the same denominator gives the same ratio. The intercept is \(\hat{\alpha}=\bar R_i-\hat{\beta}\bar R_m\). Returns may be expressed as decimals or percentage points, provided both series use the same units; the beta is unchanged by that common rescaling.

The usual interpretation requires a suitably specified linear relationship and observations that are representative of the period and asset being assessed. For the slope to estimate the conditional sensitivity without systematic bias, the regression error must have conditional mean zero given the market returns. Dependence or unequal error variance can also make conventional standard errors and significance tests unreliable, even when the calculated slope is unchanged. A high \(R^2\) alone does not establish that the beta is stable or appropriate for a project.

Why the OLS Slope Has This Form

The formula follows from the least-squares objective. For a proposed slope \(b\) and intercept \(a\), OLS minimizes the squared residual total. First, the best intercept for a fixed slope makes the residuals sum to zero, so \(a=\bar R_i-b\bar R_m\). Substituting this intercept gives a residual for each observation equal to the asset return’s deviation from its mean minus \(b\) times the market return’s deviation from its mean.

Differentiating the resulting sum of squared residuals with respect to \(b\), and setting the derivative equal to zero, gives

$$ -2\sum_{t=1}^{n}(R_{m,t}-\bar R_m)(R_{i,t}-\bar R_i) +2b\sum_{t=1}^{n}(R_{m,t}-\bar R_m)^2=0. $$

Solving for \(b\) produces the stated covariance-to-variance ratio, as long as the market returns vary, so the denominator is not zero. This derivation explains why a large market-return deviation can have substantial influence: it contributes a squared deviation to the denominator and a paired cross-product to the numerator.

Worked Example: An Outlier Changes the Estimated Beta

A hypothetical renewable-energy supplier has five monthly returns, measured in percentage points. The market-index returns are \(-2,-1,0,1,2\), and the supplier’s returns are \(-3,-1,0,2,2\). Estimate beta, then assess what happens if the final supplier return is instead recorded as \(8\). Use OLS with an intercept.

Method. Calculate the centered cross-products and the sum of squared centered market returns. The market mean is \((-2-1+0+1+2)/5=0\), and the original asset-return mean is \((-3-1+0+2+2)/5=0\). Thus the original cross-product sum is \(6+1+0+2+4=13\), and the market squared-deviation sum is \(4+1+0+1+4=10\).

$$ \hat{\beta}_{\text{original}}=\frac{13}{10}=1.3, \qquad \hat{\alpha}_{\text{original}}=0-(1.3)(0)=0. $$

Now replace the last asset return, \(2\), with \(8\). The new asset mean is \((-3-1+0+2+8)/5=1.2\). Since the market mean remains zero, the centered cross-product sum is also the sum of market return times asset return: \((-2)(-3)+(-1)(-1)+(0)(0)+(1)(2)+(2)(8)=6+1+0+2+16=25\). The denominator remains \(10\).

$$ \hat{\beta}_{\text{outlier}}=\frac{25}{10}=2.5, \qquad \hat{\alpha}_{\text{outlier}}=1.2-(2.5)(0)=1.2. $$

The single changed observation raises the estimated beta from \(1.3\) to \(2.5\). The large change is a warning to inspect the observation and its influence. It is not, by itself, evidence that the value should be deleted: verify the data, investigate any event or recording issue, and report a justified treatment. Common mistake avoided: deleting an inconvenient extreme return merely because it moves beta substantially.

Frequency, Estimation Period, and Index Choice

Return frequency. Daily data provide many observations but may include microstructure noise, nonsynchronous trading, and short-term effects that are not relevant to the intended project horizon. Monthly data often reduce some of that noise but provide fewer observations. Quarterly data reduce the number further and can conceal changes within a quarter. The compared asset and index returns must cover the same periods and use consistent definitions. A beta is a slope, not an annual return: multiplying a monthly beta by 12 is not an annualization method.

Under restrictive conditions, changing the time unit need not change beta. For example, if returns aggregate additively and both the covariance and market variance scale by the same factor, their ratio is unchanged. In practice, compounding, serial dependence, asynchronous price updates, and changes in risk can make estimates at different frequencies differ. A difference should prompt investigation rather than an automatic preference for the higher-frequency estimate.

Estimation period. A longer window generally supplies more observations and may reduce sampling noise if the asset’s relationship with the market is stable. But older observations may describe a different business mix, operating environment, or financing structure. A shorter window is more current but can be noisy and unusually affected by a brief episode. Compare reasonable windows, note relevant structural changes, and treat marked differences as uncertainty about the beta rather than proof that one window is universally correct.

Market index. Beta is defined relative to the selected market return series. Different indexes have different constituents and weights, so they can produce different covariances with the asset. Select an index that represents the relevant market and maintain a consistent basis when comparing estimates. An index choice is a modeling decision, not a way to select whichever beta gives the desired project decision.

Worked Example: Index Choice and the Implied Project Rate

A hypothetical equipment business has four monthly returns \(-2,0,2,4\) percentage points. A broad index has returns \(-2,-1,1,2\); a sector index has returns \(-1,-2,2,1\). Estimate beta against each index. Then, using a risk-free rate of \(4\%\) and a market risk premium of \(5\%\), calculate the CAPM cost of equity implied by each estimate.

Method. For the broad index, its mean is zero, its squared-deviation sum is \(4+1+1+4=10\), and the business mean is \((-2+0+2+4)/4=1\). The centered cross-product sum is \(4+0+2+8=14\), because the broad-index deviations sum to zero.

$$ \hat{\beta}_{\text{broad}}=\frac{14}{10}=1.4, \qquad \hat{\alpha}_{\text{broad}}=1-(1.4)(0)=1. $$

For the sector index, its mean is also zero. Its squared-deviation sum is \(1+4+4+1=10\), and its cross-product sum with business returns is \(2+0+4+4=10\). Therefore,

$$ \hat{\beta}_{\text{sector}}=\frac{10}{10}=1.0, \qquad \hat{\alpha}_{\text{sector}}=1-(1.0)(0)=1. $$

Under the CAPM, the cost of equity is \(r_e=r_f+\beta(r_m-r_f)\), where \(r_f\) is the risk-free rate and \(r_m-r_f\) is the market risk premium. The broad-index estimate implies \(4\%+1.4(5\%)=11\%\). The sector-index estimate implies \(4\%+1.0(5\%)=9\%\). The two-percentage-point difference comes from the index-dependent beta estimate, not a change in the risk-free rate or premium. Common mistake avoided: treating beta as independent of the market proxy or multiplying a monthly beta by 12.

Thin Trading and Nonsynchronous Returns

A security that trades infrequently may not incorporate market information into its observed price at the same time as a frequently traded index. Its measured return can therefore respond with a delay. A regression of contemporaneous returns may understate the asset’s market sensitivity, although the size and direction of the effect depend on the timing pattern and data. This is especially important when a sparse series is paired with daily index returns.

Possible diagnostics include checking trading frequency and zero-return days, comparing estimates at a lower frequency, and examining whether lagged or leading index returns help explain the asset’s returns. Such checks can reveal timing mismatch, but a lead-lag regression is a diagnostic or alternative specification, not a universal correction. The appropriate treatment depends on the data and the purpose of the beta.

Worked Example: A Delayed Price Response

In a hypothetical illustration, the contemporaneous monthly market returns are \(-2,-1,1,2\) percentage points. If the supplier’s prices updated immediately, its returns would be exactly twice the market returns: \(-4,-2,2,4\). Instead, suppose thin trading delays its response by one month, and the corresponding prior-month market returns are \(-1,-1,1,1\). The observed supplier returns are then \(-2,-2,2,2\). Compare the contemporaneous OLS slopes.

Method. Both current market-return series have mean zero, and their squared-deviation sum is \((-2)^2+(-1)^2+1^2+2^2=10\). With immediate updating, the cross-product sum is \(8+2+2+8=20\), giving

$$ \hat{\beta}_{\text{immediate}}=\frac{20}{10}=2.0. $$

For the delayed observed returns, the cross-product sum is \(4+2+2+4=12\), so

$$ \hat{\beta}_{\text{delayed}}=\frac{12}{10}=1.2. $$

In this constructed case, the contemporaneous estimate is lower because some response is associated with earlier market returns rather than the current month’s return. Actual data need not produce this exact direction or magnitude. Common mistake avoided: concluding from a low contemporaneous beta alone that a thinly traded asset has low systematic risk, without checking whether returns are synchronized.

Using Diagnostics for Project Discounting

A project’s discount rate should reflect its relevant risk, not simply the beta that is easiest to obtain. The earlier material on separating operating risk from financing risk is useful here: regression diagnostics concern the quality and interpretation of the estimated return sensitivity, while leverage adjustments address a separate question. A sound workflow keeps those questions distinct.

1
Match the observations.
Use asset and index returns for the same dates, frequency, currency, and return basis. Check for missing observations and stale prices.
2
Review the estimation choices.
State the market index and estimation window. Compare plausible alternatives if the choices materially affect the result.
3
Inspect unusual observations.
Verify extreme returns and assess their influence. Do not remove valid observations solely because they produce an inconvenient estimate.
4
Connect the estimate to the project carefully.
Use beta in the CAPM only with an appropriate market risk premium and a relevant risk estimate; carry material estimation uncertainty into the discount-rate assessment.

The central practical implication is that diagnostics can change a project rate enough to matter. For example, with a fixed \(5\%\) market risk premium, a beta difference of \(0.4\) changes the CAPM cost of equity by \(0.4(5\%)=2\) percentage points. That calculation does not prove which beta is right; it quantifies why the estimation choices deserve attention.

Common Diagnostic Traps

  • Annualizing beta like a return. Beta is a ratio of covariance to market variance, not a periodic rate. Do not multiply a monthly beta by 12.
  • Equating a longer window with a better estimate. More observations can help, but an older window may represent a different business or risk environment.
  • Assuming every extreme return is bad data. Check and investigate it. A genuine market or company event may belong in the estimate.
  • Ignoring the index definition. A beta is relative to the index used; report the proxy and consider whether it is relevant.
  • Reading low \(R^2\) as a direct beta correction. \(R^2\) describes the fraction of sample return variation explained by the fitted regression; it does not supply a formula for adjusting beta.

A defensible beta estimate is therefore accompanied by its frequency, estimation period, market index, and relevant data limitations. When plausible choices produce meaningfully different estimates, present that sensitivity rather than implying false precision. This approach is aligned with the SOA VEE Accounting and Finance syllabus.

Check Your Understanding

Work each problem before checking its final answer.

  1. A monthly regression gives covariance \(0.0036\) and market-return variance \(0.0024\), calculated on a consistent basis. What is beta, and what would the beta be after multiplying it by 12 as an alleged annualization? (Answer: \(\hat{\beta}=1.5\); multiplying by 12 gives 18, which is not a valid annualized beta.)
  2. A company’s estimated beta is \(0.9\) using a four-year monthly window and \(1.3\) using a ten-year monthly window. Name two reasons the results may differ and one useful diagnostic response. (Answer: Sampling variation, changing business or financing risk, or different unusual periods can explain the difference; compare the windows and investigate structural changes and influential observations.)
  3. A thinly traded asset has many zero daily returns, while the index trades every day. What problem can this create for a contemporaneous daily beta, and name one diagnostic. (Answer: Nonsynchronous price updates can distort or understate measured contemporaneous sensitivity; compare lower-frequency estimates or examine lead-lag index relationships.)
  4. Two reasonable indexes produce betas of \(0.8\) and \(1.1\). With a \(3\%\) risk-free rate and a \(6\%\) market risk premium, calculate each CAPM cost of equity and their difference. (Answer: \(7.8\%\) and \(9.6\%\), respectively; the difference is \(1.8\) percentage points.)
  5. An observation is confirmed as a genuine return during a major operating announcement and has substantial influence on beta. Should it be deleted automatically, and what should the analyst do? (Answer: No. Retain it unless a defensible estimation objective supports another treatment; report its influence and investigate beta sensitivity with and without it.)
Clinical Biostats